174 related articles for article (PubMed ID: 32550195)
1. Association Between Metabolic Syndrome and Diabetes Mellitus According to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III Criteria: a Cross-sectional Study.
James M; Varghese TP; Sharma R; Chand S
J Diabetes Metab Disord; 2020 Jun; 19(1):437-443. PubMed ID: 32550195
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
[TBL] [Abstract][Full Text] [Related]
4. Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation Criterion.
Tuteja HS; Nassikar N; Panikar K; Tiwaskar M; Walwalkar S; Sachdev I; Kamble S; Kadir P; Mahajan A; Joshi S; Panikar V
J Assoc Physicians India; 2024 Jun; 72(6):39-43. PubMed ID: 38881133
[TBL] [Abstract][Full Text] [Related]
5. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Prevalence and Components of Metabolic Syndrome in Sub-Saharan African Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.
Musilanga N; Nasib H; Jackson G; Shayo F; Nhanga C; Girukwigomba S; Mwakibolwa A; Henry S; Kijusya K; Msonge E
J Obes; 2024; 2024():1240457. PubMed ID: 38410415
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome among overweight and obese adults in Palestinian refugee camps.
Damiri B; Abualsoud MS; Samara AM; Salameh SK
Diabetol Metab Syndr; 2018; 10():34. PubMed ID: 29713387
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
[TBL] [Abstract][Full Text] [Related]
10. Association of metabolic syndrome with chronic obstructive pulmonary disease in an Indian population.
Acharyya A; Shahjahan MD; Mesbah FB; Dey SK; Ali L
Lung India; 2016; 33(4):385-90. PubMed ID: 27578930
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi-Libya: A pilot study.
Alshkri M; Elmehdawi R
Libyan J Med; 2008 Dec; 3(4):177-80. PubMed ID: 21499470
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey.
Ravikiran M; Bhansali A; Ravikumar P; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada S; Walia R
Diabetes Res Clin Pract; 2010 Aug; 89(2):181-8. PubMed ID: 20381187
[TBL] [Abstract][Full Text] [Related]
13. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Metabolic Syndrome among Korean Adolescents According to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation.
Kim S; So WY
Nutrients; 2016 Oct; 8(10):. PubMed ID: 27706073
[TBL] [Abstract][Full Text] [Related]
15. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
[TBL] [Abstract][Full Text] [Related]
16. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?
Rezaianzadeh A; Namayandeh SM; Sadr SM
Int J Prev Med; 2012 Aug; 3(8):552-8. PubMed ID: 22973485
[TBL] [Abstract][Full Text] [Related]
17. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
Bee YT; Haresh KK; Rajibans S
Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
20. Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes.
Saif-Ali R; Kamaruddin NA; Al-Habori M; Al-Dubai SA; Ngah WZW
Diabetol Metab Syndr; 2020; 12():67. PubMed ID: 32774471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
